Xueli Bai

机构：Zhejiang International Studies University, Zhejiang Cancer Hospital, First Affiliated Hospital Zhejiang University, Zhejiang University · ORCID：0000-0002-2934-0880

发表论文 231 篇 · 总被引 9238 次 · h-index 51

代表论文

• Oncolytic virus VG161 in refractory hepatocellular carcinoma (2025 · Nature · 被引 82)
• China Liver Cancer Guidelines for the Diagnosis and Treatment of Hepatocellular Carcinoma (2024 Edition) (2025 · Liver Cancer · 被引 43)
• ADSL-generated fumarate binds and inhibits STING to promote tumour immune evasion (2025 · Nature Cell Biology · 被引 36)
• Sphingolipid synthesis in tumor-associated macrophages confers immunotherapy resistance in hepatocellular carcinoma (2025 · Science Advances · 被引 30)
• PSAT1 impairs ferroptosis and reduces immunotherapy efficacy via GPX4 hydroxylation (2025 · Nature Chemical Biology · 被引 23)
• Lipid metabolism reprograming by SREBP1‐PCSK9 targeting sensitizes pancreatic cancer to immunochemotherapy (2025 · 癌症：英文版 · 被引 22)